|
Clearside Biomedical Inc (NASDAQ: CLSD) |
|
Clearside Biomedical Inc
CLSD's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Clearside Biomedical Inc growth rates, revenue grew
by 20.84 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 254
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
Clearside Biomedical Inc net loss decreased from $-9 millions, to $-8 millions in III. Quarter 2024,
• More on CLSD's Growth
|
|
Clearside Biomedical Inc realized a net loss in trailing twelve months.
Clearside Biomedical Inc realized cash reduction of $ -0.2 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.
• More on CLSD's Valuation
|
|
|
|
|
Clearside Biomedical Inc realized net loss in trailing twelve months.
Clearside Biomedical Inc realized cash outflow of $ -0.2per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 9.02.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.23.
• More on CLSD's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com